Literature DB >> 8065347

Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation.

W M Rideout1, P Eversole-Cire, C H Spruck, C M Hustad, G A Coetzee, F A Gonzales, P A Jones.   

Abstract

Alterations in DNA methylation patterns are one of the earliest and most common events in tumorigenesis. Overall levels of genomic methylation often decrease during transformation, but localized regions of increased methylation have been observed in the same tumors. We have examined changes in the methylation status of the muscle determination gene myoD, which contains a CpG island, as a function of oncogenic transformation. This CpG island underwent de novo methylation during immortalization of 10T1/2 cells, and progressively more sites became methylated during the subsequent transformation of the cells to oncogenicity. The greatest increase in methylation occurred in the middle of the CpG island in exon 1 during transformation. Interestingly, no methylation was apparent in the putative promoter of myoD in either the 10T1/2 cell line or its transformed derivative. The large number of sites in the CpG island that became methylated during transformation was correlated with heterochromatinization of myoD as evidenced by a decreased sensitivity to cleavage of DNA in nuclei by MspI. A site in the putative promoter also became insensitive to MspI digestion in nuclei, suggesting that the chromatin structural changes extended beyond the areas of de novo methylation. Unlike Lyonized genes on the inactive X chromosome, whose timing of replication is shifted to late S phase, myoD replicated early in S phase in the transformed cell line. Methylation analysis of myoD in DNAs from several human tumors, which presumably do not express the gene, showed that hypermethylation also frequently occurs during carcinogenesis in vivo. Thus, the progressive increase in methylation of myoD during immortalization and transformation coinciding with a change in chromatin structure, as illustrated by the in vitro tumorigenic model, may represent a common mechanism in carcinogenesis for permanently silencing the expression of genes which can influence cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065347      PMCID: PMC359141          DOI: 10.1128/mcb.14.9.6143-6152.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.

Authors:  J D Lewis; R R Meehan; W J Henzel; I Maurer-Fogy; P Jeppesen; F Klein; A Bird
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

2.  Inactive chromatin spreads from a focus of methylation.

Authors:  S U Kass; J P Goddard; R L Adams
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

3.  Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.

Authors:  S M Taylor; P A Jones
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

4.  Parental-origin-specific epigenetic modification of the mouse H19 gene.

Authors:  A C Ferguson-Smith; H Sasaki; B M Cattanach; M A Surani
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

5.  Association of fragile X syndrome with delayed replication of the FMR1 gene.

Authors:  R S Hansen; T K Canfield; M M Lamb; S M Gartler; C D Laird
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

6.  5-methylcytosine is localized in nucleosomes that contain histone H1.

Authors:  D J Ball; D S Gross; W T Garrard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene.

Authors:  H Sasaki; P A Jones; J R Chaillet; A C Ferguson-Smith; S C Barton; W Reik; M A Surani
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

8.  Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal.

Authors:  R Stöger; P Kubicka; C G Liu; T Kafri; A Razin; H Cedar; D P Barlow
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

9.  Activation of an imprinted Igf 2 gene in mouse somatic cell cultures.

Authors:  P Eversole-Cire; A C Ferguson-Smith; H Sasaki; K D Brown; B M Cattanach; F A Gonzales; M A Surani; P A Jones
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

10.  Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.

Authors:  S J Tapscott; M J Thayer; H Weintraub
Journal:  Science       Date:  1993-03-05       Impact factor: 47.728

View more
  21 in total

1.  Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning.

Authors:  S A Patel; D M Graunke; R O Pieper
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements.

Authors:  Gangning Liang; Matilda F Chan; Yoshitaka Tomigahara; Yvonne C Tsai; Felicidad A Gonzales; En Li; Peter W Laird; Peter A Jones
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region.

Authors:  G Benvenuto; M L Carpentieri; P Salvatore; L Cindolo; C B Bruni; L Chiariotti
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

4.  Regulation of the expression of the tissue transglutaminase gene by DNA methylation.

Authors:  S Lu; P J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene.

Authors:  S Contente; K Kenyon; P Sriraman; S Subramanyan; R M Friedman
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

6.  Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation.

Authors:  J Y Fang; J A Mikovits; R Bagni; C L Petrow-Sadowski; F W Ruscetti
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  MyoD is a tumor suppressor gene in medulloblastoma.

Authors:  Joyoti Dey; Adrian M Dubuc; Kyle D Pedro; Derek Thirstrup; Brig Mecham; Paul A Northcott; Xiaochong Wu; David Shih; Stephen J Tapscott; Michael LeBlanc; Michael D Taylor; James M Olson
Journal:  Cancer Res       Date:  2013-10-03       Impact factor: 12.701

8.  Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences.

Authors:  R Remus; C Kämmer; H Heller; B Schmitz; G Schell; W Doerfler
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation.

Authors:  Gyeong Hoon Kang; Hyeon Joo Lee; Kyu Sang Hwang; Sun Lee; Jae-Hoon Kim; Jung-Sun Kim
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Tissue-specific variation in DNA methylation levels along human chromosome 1.

Authors:  Cecilia De Bustos; Edward Ramos; Janet M Young; Robert K Tran; Uwe Menzel; Cordelia F Langford; Evan E Eichler; Li Hsu; Steve Henikoff; Jan P Dumanski; Barbara J Trask
Journal:  Epigenetics Chromatin       Date:  2009-06-08       Impact factor: 4.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.